🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

8 recruiting trials

for NENS

Zanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (HG-NENs) NCT06926634Phase 22 sites📍 Rochester📍 St Louis Washington University School of Medicine · Tests: Zanzalintinib Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC) NCT05237934n/a1 site📍 Bethesda National Cancer Institute (NCI) Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe Study NCT05554003Phase 21 site📍 Milan European Institute of Oncology · Tests: Temozolomide capsule Influence of Tumour and Patient's Related Factors on the Response to Medical Treatments in Well Differentiated GEP-NENs NCT06356467n/a1 site📍 Milan IRCCS San Raffaele A Trial Evaluating the Activity and Safety of Combination Between Cabozantinib and Temozolomide in Lung and GEP-NENS Progressive After Everolimus, Sunitinib or PRRT (CABOTEM) NCT04893785Phase 21 site📍 Naples National Cancer Institute, Naples · Tests: Cabozantinib and Temozolomide A Phase I Study to Assess the Safety and Efficacy of [225Ac]Ac-DOTATATE in Patients With SSTR+ GEP-Nens NCT06732505Phase 11 site📍 Beijing Peking University Cancer Hospital & Institute · Tests: [225Ac]Ac-DOTATATE NALIRIFOX as Second-Line Chemotherapy in Extrapulmonary High-grade Neuroendocrine Neoplasms: a Prospective, Single-center, Single-arm Trial NCT07077551Phase 21 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: NALIRIFOX PRRT Versus PRRT Plus Chemotherapy in GEP NET (PReCedeNT Trial) NCT07185672Phase 32 sites📍 Mumbai📍 Navi Mumbai Tata Memorial Hospital · Tests: Peptide Receptor Radionuclide Therapy with Lu177 DOTATATE, Capecitabine plus temozolamide
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy